Literature DB >> 2449680

Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.

A Ferrandez-Izquierdo1, A Llombart-Bosch.   

Abstract

Primary liver carcinoma (PLC) may express a certain number of markers. Here we communicate results of an analysis of five such markers (alpha-1-antitrypsin--AAT--, carcino-embryonic antigen --CEA--, alpha-fetoprotein --AFP--, and superficial --HBsAg-- and core --HBcAg-- antigens of hepatitis B virus) by means of PAP techniques in 130 cases of PLC, comparing the neoplastic tissue and the non-tumorous liver. Three variants of PLC are distinguished: hepatocarcinoma (HC) (108 cases); cholangiocarcinoma (CC) (19 cases); and three cases of hepatocholangiocarcinoma (HCC). AAT was positive in 29 HC, 2 HCC, and negative in all 19 CC. CEA appeared positive in 16 HC, 16 CC and only one HCC. AFP was positive in two HC, and negative in all CC and HCC. HBsAg displayed positivity in 15 HC and one HCC, being negative in all 19 CC. HBcAg was positive in 4 HC, and negative in all CC and HCC. HBsAg was also positive in two neoplastic emboli associated with HC. On the non-tumorous liver tissue the immunohistochemical results showed positivity for AAT and CEA, but not for AFP. Therefore the present results confirm that in the geographical area from which these tumors proceed, PLC is closely correlated with HBsAg positivity and with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2449680     DOI: 10.1016/S0344-0338(87)80043-2

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  An update on long-term outcome of curative hepatic resection for hepatocholangiocarcinoma.

Authors:  Kenneth Siu-Ho Chok; Kelvin K C Ng; Tan To Cheung; Wai Key Yuen; Ronnie T P Poon; Chung Mau Lo; Sheung Tat Fan
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

2.  Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.

Authors:  K Sideras; S J Bots; K Biermann; D Sprengers; W G Polak; J N M IJzermans; R A de Man; Q Pan; S Sleijfer; M J Bruno; J Kwekkeboom
Journal:  Br J Cancer       Date:  2015-06-09       Impact factor: 7.640

3.  Importance of surgical margin in the outcomes of hepatocholangiocarcinoma.

Authors:  Ka Wing Ma; Kenneth Siu Ho Chok
Journal:  World J Hepatol       Date:  2017-05-08

4.  A case of combined hepatocellular-cholangiocarcinoma with underlying schistosomiasis.

Authors:  Chang Kyun Hong; Jin Mo Yang; Bong Koo Kang; Jin Dong Kim; Young Chul Kim; U-Im Chang; Jin Young Yoo
Journal:  Korean J Intern Med       Date:  2007-12       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.